Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Obviously sciv, tigger thinks you were talking about the current trials...
This is what they feed investors
http://www.pmlive.com/pharma_news/positive_copd_data_for_synairgens_sng001_supports_covid-19_programme_1349008?SQ_DESIGN_NAME=2&
He added that, despite the encouraging data in COPD, this particular programme will be paused as the company’s “immediate priority” is to advance testing of SNG001 in COVID-19.
This is what they told the activ 2 people who they can't fed with bs
"Originally, up to 120 patients in total were to be randomized during Part 2, however, due to the SARS-CoV-19 pandemic in 2020, the study was paused and an interim analysis was conducted of all currently available data in order to aid decision making with respect to the potential of SNG001 in treating and preventing COVID-19 symptoms. At this time, 109 (placebo, n=52; SNG001, n=57) patients had been randomized and following the interim analysis a decision was made to *close the trial*. "
"Although there was no statistically significant difference in total BCSS in this group over the treatment period, there was a trend towards improvement of the breathlessness component of the score, suggesting that patients may have recovered more rapidly if they received SNG001 rather than placebo. Viral infections had less impact on non-exacerbating patients and there were no significant treatment effects. Biomarker analysis showed that in the overall population COPD patients inhaling SNG001 had significantly increased markers of antiviral activity."
These are from the activ document in the background section for sng. The second part they also published in an RNS last september, as you can see there is a "suggestion" but not really conclusive. More importantly, in the first part above, they clarify that they initally paused the trial and then *closed* it *after* the interim analysis. They never told this to investors directly afaik but do correct me if I'm wrong. So they have to do it again but better. Once again, it seems to me if there were enough patients with exarcebation it would have been enough to apply for a phase 3 but now it does not seem to.
Fantastic opportunity to buy some more
Thanks MM’s and derampers, made my day
Thanks for the reply Tigg, I'm genuinely interested how you came to the figure though, is that from technical analysis or more of a hunch, I'm not disputing your call btw, I can see it drifting further too.
Hi Scinc_temp ... The company advised they have dropped all the trails ... where does it say that , as I cant find it ...
Bad karma to lie on this scale and ensure the weak who have held on for so long to bail ....
please send us all the link to back up your statement ...
I'm looking at the daily chart and all I can see is a U-bend shape followed by 2 massive spikes of Tigger poo. I think this is indicative of rising BS levels. The bottom seems to have been engaged already, but the dump did not happen, and so I believe we are in for a huge flush. All IMO though, DYOR.
But again this is a patient stratification issue probably, rather thana treatment issue. Why do they keep doing the same trial again and again instead of working out what is the profile of patients that should receive it is my question.
We have all seen the price go up to £2.50 and drop to below £1, either believe in the science and company and hold or don't, dump your shares and move on. Personally I am holding.
Tiger the company said so.
Not enough exarcebations
Barry Brown peas : Hi
The market is reluctant to invest in a therapeutic due to the Vaccine roll out .. Looking at the flow charts , and the sentiment , and the days that go by with no new (RNS) the SP will loose drive ..
135 I believe is the bottom as this would realistically be a bargain price according to the market should approvals take fusion ... yet I don't see the SP falling to this range until next week at some point ...
Also and this goes out to Dump ,you post is not reality , and a complete lie ... where does it state the P2 trails did not go ahead .....and SNG dose not work ... what a bold statement ... rubbish ....
15 years of research .. the best team ever ..
Out of interest, what makes you think £1.35 Is the bottom?
Well I did predict that the SP would fall and we have some time to wait for results and that Super RNS ...
However my plan with ARB hasn't taken fusion either ,as BTC is consolidating .. something that wasn't prevalent in my research ... yet with the massive sale of coin base tomorrow ..BTC set to rise which has a direct influence on ARB ...
I need to sell out , as I feel we are close to news here , but not until May my new research tells me ... so may hold my funds as cash .. any tips anyone ..?
This is defiantly a ideal time to be looking to buy SNG , yet I will wait until it falls close to 140 - 135... I really don't see it go less than this ....
Have a great day everyone ...